| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Prasugrel-d5
CAS:1127252-92-9
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Hubei Xinyang Medical Technology Co., Ltd
|
| Tel: |
15347293736 15347293736 |
| Email: |
2853117764@qq.com |
| Products Intro: |
Product Name:Prasugrel-d5
CAS:1127252-92-9
Purity:99% HPLC Package:10mg；25mg；50mg；100mg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:Prasugrel-d5
CAS:1127252-92-9
Purity:NULL Package:10mg;1mg Remarks:NULL
|
|
| | Prasugrel-d5 Basic information |
| | Prasugrel-d5 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Chloroform: slightly soluble,Methanol: slightly soluble | | form | A solid |
| | Prasugrel-d5 Usage And Synthesis |
| Description | Prasugrel-d5 is intended for use as an internal standard for the quantification of prasugrel by GC- or LC-MS. Prasugrel is a prodrug form of the platelet purinergic P2Y12 receptor antagonist R-99224. Prasugrel (0.3 and 3 mg/kg) inhibits ex vivo washed platelet aggregation in rat platelet rich-plasma. In vivo, prasugrel prevents thrombus formation (ED50 = 0.68 mg/kg) and increases tail bleeding time in rats. Formulations containing prasugrel have been used in the prevention of blood clots. | | Uses | A novel labelled antiplatelet agent; it is a third-generation thienopyridine. Antiplatelet agent Prasugrel showed greater platelet inhibition and decreased incidence of ischemic events than Clopidogrel but may induce increased incidence of bleeding in patient with acute coronary syndrome |
| | Prasugrel-d5 Preparation Products And Raw materials |
|